Apyx Medical Corporation (APYX)
NASDAQ: APYX · Real-Time Price · USD
3.460
0.00 (0.00%)
Jan 8, 2026, 4:00 PM EST - Market closed
Apyx Medical Market Cap
Apyx Medical has a market cap or net worth of $141.96 million as of January 9, 2026. Its market cap has increased by 160.96% in one year.
Market Cap
141.96M
Enterprise Value
156.04M
1-Year Change
160.96%
Ranking
Category
Stock Price
$3.46
Market Cap Chart
Since February 22, 1999, Apyx Medical's market cap has increased from $10.20M to $141.96M, an increase of 1,291.79%. That is a compound annual growth rate of 10.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 8, 2026 | 132.30M | -1.12% |
| Dec 31, 2025 | 133.80M | 144.61% |
| Dec 31, 2024 | 54.70M | -39.76% |
| Dec 29, 2023 | 90.80M | 12.10% |
| Dec 30, 2022 | 81.00M | -81.60% |
| Dec 31, 2021 | 440.30M | 78.40% |
| Dec 31, 2020 | 246.80M | -14.63% |
| Dec 31, 2019 | 289.10M | 34.34% |
| Dec 31, 2018 | 215.20M | 151.99% |
| Dec 29, 2017 | 85.40M | -13.12% |
| Dec 30, 2016 | 98.30M | 72.15% |
| Dec 31, 2015 | 57.10M | -13.62% |
| Dec 31, 2014 | 66.10M | 72.58% |
| Dec 31, 2013 | 38.30M | -10.93% |
| Dec 31, 2012 | 43.00M | 14.36% |
| Dec 30, 2011 | 37.60M | -35.28% |
| Dec 31, 2010 | 58.10M | -56.48% |
| Dec 31, 2009 | 133.50M | 31.92% |
| Dec 31, 2008 | 101.20M | 2.64% |
| Dec 31, 2007 | 98.60M | -26.20% |
| Dec 29, 2006 | 133.60M | 221.93% |
| Dec 30, 2005 | 41.50M | 17.90% |
| Dec 31, 2004 | 35.20M | -12.87% |
| Dec 31, 2003 | 40.40M | 213.18% |
| Dec 31, 2002 | 12.90M | 21.70% |
View and export this data all the way back to 1999. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 952.72B |
| Johnson & Johnson | 493.40B |
| AbbVie | 395.77B |
| UnitedHealth Group | 316.11B |
| AstraZeneca | 293.89B |
| Merck & Co. | 270.22B |
| Novartis AG | 268.87B |
| Novo Nordisk | 253.02B |